Health & Fitness
Wed, September 1, 2010Tue, August 31, 2010Mon, August 30, 2010Sun, August 29, 2010Fri, August 27, 2010Thu, August 26, 2010Bernstein Liebhard LLP Announces Investigation on Behalf of Shareholders of Genzyme Corporation
//health-fitness.news-articles.net/content/2010/ .. half-of-shareholders-of-genzyme-corporation.html
Published in Health and Fitness on Tuesday, August 31st 2010 at 9:45 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
NEW YORK--([ BUSINESS WIRE ])--Bernstein Liebhard LLP is investigating whether the Board of Directors of Genzyme Corporation (aGenzymea or the aCompanya) (Nasdaq: GENZ) is breaching its fiduciary duty to the Companya™s shareholders by not agreeing to sell Genzyme to Sanofi-Aventis and/or not seeking to maximize value for the Companya™s shareholders.
If you are interested in discussing your rights as a Genzyme shareholder and/or have information relating to the matter, please contact U. Seth Ottensoser at (877) 779-1414 or [ Ottensoser@bernlieb.com ].
Bernstein Liebhard has pursued hundreds of securities, [ consumer ] and shareholder rights cases and recovered almost $3 billion for its clients. It has been named to The National Law Journala™s aPlaintiffsa™ Hot Lista in each of the last seven years.
| Bernstein Liebhard LLP |
| 10 East 40th Street |
| New York, New York 10016 |
| (877) 779-1414 |
[ www.bernlieb.com ] |
ATTORNEY ADVERTISING. © 2010 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.